Jump to content
RemedySpot.com

Re: Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 07

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Very Welcome News!

(Chuck) Maack

Prostate Cancer Advocate

Bio: http://www.ustoowichita.org/leaders.cfm?content=bio & id=1

Email: maack1@...

>

>

http://money.cnn.com/news/newsfeeds/articles/prnewswire/CLTU0662310200

7-1.htm

> Dendreon Completes Target Enrollment of 500 Patients in Phase 3

IMPACT Study

> of Provenge® For Advanced Prostate Cancer

> --FDA Has Agreed That Positive Survival Data from IMPACT Study

Would Support

> Licensure of PROVENGE---Interim Survival Results Expected in Second

Half of

> 2008--

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...